Skip to content
Chandler Knee Soreness Guide
Knee PRP findings, sorted without the sales gloss

Chandler Knee Soreness Guide

Common questions about knee PRP made from your spun blood

You'll find straight answers to common knee PRP questions here. PRP means platelet-rich plasma: the office spins your blood and keeps plasma carrying extra platelets, small cells that gather at a cut. Your knee exam and health can change some answers. Take any questions left over to the visit.

What may PRP do for a sore knee?

PRP may ease soreness and help some people use the knee more easily, but it hasn't helped everyone in careful research. Studies don't show that it rebuilds worn cartilage. An exam can tell you whether discussing it is reasonable.

Does PRP work?

Sometimes, but there isn't a sure result. Some comparisons favored PRP over steroid or gel care later on. In another test, a group received salt water without prepared blood, and PRP added no clear relief. Your clinician can explain both findings without a promise.

When is knee PRP worth considering?

It may be worth discussing after exercise, a brace, or medicine hasn't helped enough. The cause and amount of joint wear matter, and paying cash matters when relief isn't certain. Decide which daily task must become easier before you pay.

How does PRP compare with a cortisone shot?

Cortisone often aims for quicker relief that doesn't last as long. Some PRP studies found more relief later, though the research isn't settled. The fair choice depends on your knee, earlier care, and how soon you need help, so ask about each treatment's limits.

What happens at a PRP visit?

The office draws your blood and spins it to separate the layers. Plasma holding extra clot-making platelets is kept and placed at the sore knee. Offices may keep different amounts of platelets or white blood cells. Ask why the chosen method fits your knee and how many visits the clinician expects.

When isn't PRP a good fit?

An active infection or certain bleeding problems may rule it out or delay it. Blood thinners and aspirin need careful review. Severe joint wear may make another choice more useful. You mustn't stop prescribed medicine without direct instructions.

What should I avoid after PRP?

Follow the clinic's advice for walking, driving, work, and exercise. Don't copy another person's schedule, because standing all day is different from desk work. Medicine changes also need direct advice. Call promptly if heat, redness, fever, or swelling gets worse.

Will insurance pay for knee PRP in Arizona?

Often it won't. Medicare's narrow PRP coverage doesn't include routine care for knee arthritis. Other insurance plans differ, so check with the plan and clinic. Get the complete price in writing before scheduling.

Sources

  1. In the RESTORE trial - the largest placebo-controlled PRP trial in knee osteoarthritis - 288 adults aged 50+ with symptomatic Kellgren-Lawrence grade 2-3 medial knee OA received three weekly intra-articular injections of leukocyte-poor PRP from a commercial system or saline placebo. At 12 months the mean change in knee pain was -2.1 points with PRP versus -1.8 with saline (difference -0.4; 95% CI -0.9 to 0.2; P=.17) against a minimum clinically important difference of 1.8, and the change in medial tibial cartilage volume was -1.4% versus -1.2% (difference -0.2%; 95% CI -1.9% to 1.5%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no significant between-group difference. The authors concluded the findings do not support use of PRP for knee OA.

    Bennell KL, Paterson KL, Metcalf BR, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

  2. A meta-analysis of 34 randomized trials (1403 PRP knees, 1426 control knees) found WOMAC favoured PRP over placebo at 12 months (P=.02) and over hyaluronic acid at 6 and 12 months (P<.001), and favoured PRP over steroids on VAS pain and KOOS at 6 months. Critically, the authors reported that the superiority of PRP did NOT reach the minimal clinically important difference for any outcome, and graded the quality of evidence as low.

    Filardo G, Previtali D, Napoli F, et al. — PRP Injections for the Treatment of Knee Osteoarthritis: A Meta-Analysis of Randomized Controlled Trials. Cartilage, 2021. DOI: 10.1177/1947603520931170.

  3. A meta-analysis of eight studies (648 patients, mean age 59) judged at low risk of bias found PRP significantly better than intra-articular corticosteroid for knee OA symptoms at 3, 6 and 9 months (P<0.01), with the largest effects at 6 months (SMD -0.78; 95% CI -1.34 to -0.23) and 9 months (SMD -1.63; 95% CI -2.14 to -1.12). This is the strongest available case for PRP as a longer-acting alternative to a steroid shot.

    McLarnon M, Heron N — Intra-articular platelet-rich plasma injections versus intra-articular corticosteroid injections for symptomatic management of knee osteoarthritis: systematic review and meta-analysis. BMC Musculoskeletal Disorders, 2021. DOI: 10.1186/s12891-021-04308-3.

  4. The devices used to spin PRP at the point of care are cleared by FDA as clinical centrifuges, product code JQC, a Class I device under 21 CFR 862.2050 - for example the Biomet GPS Platelet Separation Kit (K030555, cleared 2003) and the Harvest SmartPrep2 / SmartPrep Platelet Concentration System (K103340, cleared 2010). That clearance covers the equipment that separates blood. It is not an FDA approval of platelet-rich plasma as a treatment for osteoarthritis, tendinopathy or any other orthopedic condition, and copy must never blur the two.

    U.S. Food and Drug Administration (Center for Devices and Radiological Health) — 510(k) Premarket Notification database and Product Classification: JQC, Centrifuges (Micro, Ultra, Refrigerated) For Clinical Use, 21 CFR 862.2050. FDA accessdata (CDRH device databases), 2003.

  5. Medicare's national coverage policy covers autologous platelet-rich plasma ONLY for patients with chronic non-healing diabetic, pressure and/or venous wounds, and only within an approved coverage-with-evidence-development clinical study. There is no Medicare national coverage for PRP in osteoarthritis or tendinopathy, which is why these injections are billed to the patient as cash-pay.

    Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2024.

  6. A systematic review and meta-analysis of adverse events in randomized trials of intra-articular PRP for knee osteoarthritis found PRP associated with mild, transient adverse events - knee pain and swelling - that typically resolve without intervention, and more frequent with LEUKOCYTE-RICH formulations. Leukocyte-poor PRP had a safety profile similar to hyaluronic acid. Knee stiffness was more frequent with PRP than with normal saline (P=.031). No severe adverse events were reported in any group.

    Nakagawa HF, Kim J, Rabinowitz J, et al. — Assessment of adverse events and safety associated with intra-articular platelet-rich plasma injections compared to other injectates for knee osteoarthritis: A systematic review and meta-analysis. PM&R, 2026. DOI: 10.1002/pmrj.70141.

  7. The ESSKA-ICRS consensus applied the RAND/UCLA appropriateness method to 216 clinical scenarios for intra-articular PRP in knee OA. Only 84 scenarios (38.9%) were rated appropriate, 9 (4.2%) inappropriate and 123 (56.9%) uncertain. PRP was judged appropriate in patients aged 80 or under with KL grade 0-III osteoarthritis AFTER failed conservative non-injective or injective treatment; it was NOT considered appropriate as a first treatment, nor in KL grade IV (bone-on-bone) osteoarthritis, where 91.7% and 87.5% of scenarios respectively were uncertain.

    Kon E, de Girolamo L, Laver L, et al. — Platelet-rich plasma injections for the management of knee osteoarthritis: The ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surgery, Sports Traumatology, Arthroscopy, 2024. DOI: 10.1002/ksa.12320.

  8. A systematic review of 105 clinical PRP studies in orthopaedics published 2006-2016 found that only 11 (10%) described the preparation protocol clearly enough for another investigator to repeat it, and only 17 (16%) reported any quantitative metric of the final PRP composition. The authors concluded that the current reporting of PRP preparation and composition does not allow the PRP products actually delivered to patients to be compared between studies.

    Chahla J, Cinque ME, Piuzzi NS, et al. — A Call for Standardization in Platelet-Rich Plasma Preparation Protocols and Composition Reporting: A Systematic Review of the Clinical Orthopaedic Literature. Journal of Bone and Joint Surgery (American), 2017. DOI: 10.2106/JBJS.16.01374.

Take your knee questions to the Chandler clinic

Take your medicine list, earlier knee records, and notes about activities that make the joint sore. QC Kinetix offers regenerative treatments such as PRP, which uses spun blood with plasma that holds extra clot-making platelets. The clinician can explain whether that non-surgical office care fits your knee, and you won't be promised a result.

The office is on Dobson Road south of Pecos, and the shared number is (602) 837-PAIN. Ask about cost, the visit, and the first days afterward. A clear answer can save you time and expense. That's worth having.

Book a free consultation